FDA approves first CRISPR therapy

The Food and Drug Administration on Friday approved two gene therapies to treat sickle cell disease, one of the which is the first CRISPR/Cas9-based treatment to win regulatory approval in the US. The announcement is a landmark in the treatment of sickle cell disease, a devastating condition in…#africanamericans #nicoleverdun #fda #hba #hbs #crisprcas9 #hbf #deform #cas9 #rna
Source: Reuters: Health - Category: Consumer Health News Source Type: news